OrganiGram

Licensed producer of medical marijuana in canada.

Launch date

Jul 2013

Employees

Market cap

Enterprise valuation

AUD216m (Public information from Sep 2024)

Moncton New Brunswick (HQ)

http://organigram.ca

https://twitter.com/organigraminc https://www.facebook.com/OrganiGramInc https://www.linkedin.com/company/organigram/https://play.google.com/store/apps/details?id=com.currentstudios.organigram

Revenues, earnings & profits over time

CAD	2020	2021	2022	2023	2024	2025	2026
Revenues	86.8m	79.2m	146m	155m	162m	185m	261m
% growth	5 %	(9 %)	84 %	7 %	5 %	14 %	41 %
EBITDA	(81.1m)	(42.9m)	(15.2m)	-	5.0m	14.6m	30.5m
% EBITDA margin	(93 %)	(54 %)	(10 %)	-	3 %	8 %	12 %
Profit	(136m)	(131m)	(14.3m)	-	(36.9m)	1.6m	(<1m)
% profit margin	(157 %)	(165 %)	(10 %)	-	(23 %)	1 %	-
EV / revenue	3.6x	8.7x	1.9x	0.9x	1.6x	1.4x	1.0x
EV / EBITDA	-3.9x	-16.1x	-18.7x	-	51.7x	17.6x	8.4x
R&D budget	1.3m	3.5m	6.0m	-	-	-	-
R&D % of revenue	1 %	4 %	4 %	-	-	-	-

Date	Investors	Amount	Round
Apr 2015	N/A	$5.0m	Post IPO Debt
Aug 2016	N/A	CAD23.0m	Post IPO Equity
Dec 2016*	N/A	$40.3m	Post IPO Equity
Nov 2017	N/A	CAD57.5m	Post IPO Equity
May 2019*	Bank of Montreal	$140m	Post IPO Debt
Nov 2020	N/A	CAD69.1m	Post IPO Equity
Mar 2021*	British American Tobacco	£126m	Post IPO Equity
Nov 2023*	British American Tobacco	CAD125m	Post IPO Equity
Jan 2024*	BT DE Investments	CAD125m	Post IPO Equity
Sep 2024*	BT DE Investments	N/A	Private Placement non VC
Total Funding		-

Tech stackLearn more about the technologies and tools that this company uses.

Phylos Bioscience

Green Tank Technologies

Open Book Extracts (OBX)

Edibles & Infusions Corporation

ACQUISITION by OrganiGram Apr 2021

Laurentian Organic

ACQUISITION by OrganiGram Dec 2021